Affluent Medical : 2023 financial results and update on clinical activities under development.
Affluent Medical : 2023 financial results and update on clinical activities under development.
- Affluent Medical : 2023 financial results and update on clinical activities under development.
- Affluent Medical estimates that KaliosTM would avoid repeat surgery for 30-40% of patients within five years of their operation.
- In September 2023, the Company presented interim data on 20 patients treated in five clinical centers in Europe after one year of implantation.
- In July 2023, Affluent Medical announced the appointments of Christophe de Vregille as Chief Financial Officer and Benjamin Renault as Development Director.